Aadi Bioscience, Inc. (AADI) Tops Q3 EPS by 12c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.60), $0.12 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $5.96 million versus the consensus estimate of $6.62 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• Lennar Corp. (LEN) Misses Q2 EPS by 1c